CA2275507A1 - Prebiotiques et probiotiques - Google Patents

Prebiotiques et probiotiques Download PDF

Info

Publication number
CA2275507A1
CA2275507A1 CA002275507A CA2275507A CA2275507A1 CA 2275507 A1 CA2275507 A1 CA 2275507A1 CA 002275507 A CA002275507 A CA 002275507A CA 2275507 A CA2275507 A CA 2275507A CA 2275507 A1 CA2275507 A1 CA 2275507A1
Authority
CA
Canada
Prior art keywords
beta
glucan
microorganisms
lactic acid
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002275507A
Other languages
English (en)
Inventor
Patricia Lynne Conway
Ross Crittenden
Anders Henriksson
Rachel Jane Lucas
Xin Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Burns Philp and Co Ltd
University of New South Wales
Burns Philp Research and Development Pty Ltd
Gist Brocades Australia Pty Ltd
Goodman Fielder Ingredients Ltd
Arnotts Biscuits Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Burns Philp and Co Ltd, University of New South Wales , Burns Philp Research and Development Pty Ltd, Gist Brocades Australia Pty Ltd, Goodman Fielder Ingredients Ltd, Arnotts Biscuits Ltd filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of CA2275507A1 publication Critical patent/CA2275507A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne un procédé destiné à améliorer une population commensale de micro-organismes producteurs d'acide lactique, de préférence de lactobacilles, dans le tractus gastro-intestinal d'un animal. Ce procédé comporte l'apport à cet animal d'un .beta.-glucane, d'un composé obtenu à partir de celui-ci, ou d'un de leurs mélanges, soit seul, soit en combinaison avec d'autres prébiotiques et/ou avec un ou plusieurs micro-organismes probiotiques, de sorte qu'après ingestion, le .beta.-glucane passe au travers du tractus gastro-intestinal sensiblement inutilisé, jusqu'à ce qu'il atteigne un site du tractus gastro-intestinal où il est utilisé par une population commensale de micro-organismes et/ou de micro-organismes probiotiques introduits, le cas échéant, provoquant ainsi une augmentation en nombre et/ou en activité de la population commensale de micro-organismes producteurs d'acide lactique et, le cas échéant, des micro-organismes probiotiques.
CA002275507A 1996-12-19 1997-12-18 Prebiotiques et probiotiques Abandoned CA2275507A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO4304A AUPO430496A0 (en) 1996-12-19 1996-12-19 Prebiotics and probiotics
AUPO4304 1996-12-19
PCT/AU1997/000859 WO1998026787A1 (fr) 1996-12-19 1997-12-18 Prebiotiques et probiotiques

Publications (1)

Publication Number Publication Date
CA2275507A1 true CA2275507A1 (fr) 1998-06-25

Family

ID=3798612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002275507A Abandoned CA2275507A1 (fr) 1996-12-19 1997-12-18 Prebiotiques et probiotiques

Country Status (4)

Country Link
JP (1) JP2001506129A (fr)
AU (1) AUPO430496A0 (fr)
CA (1) CA2275507A1 (fr)
WO (1) WO1998026787A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751907B4 (de) * 1997-11-22 2004-07-08 Pharma-Zentrale Gmbh Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor
DE19861497B3 (de) 1998-08-11 2017-03-30 N.V. Nutricia Babynahrung und ihre Verwendung zur Förderung der humanen Dickdarmflora
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
DE19962427A1 (de) 1999-12-22 2001-07-12 Nutrinova Gmbh Verkapselte multifunktionelle, biologisch aktive Nahrungsmittelkomponente, Verfahren zu ihrer Herstellung und ihre Anwendung
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
US20050272694A1 (en) * 2003-03-07 2005-12-08 Aureo Co., Ltd Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition
JP4000078B2 (ja) * 2003-03-07 2007-10-31 株式会社アウレオ 皮膚用保湿剤
JP4054697B2 (ja) * 2003-03-07 2008-02-27 株式会社アウレオ 便秘改善剤
US6936598B2 (en) * 2003-11-21 2005-08-30 Hill's Pet Nutrition, Inc. Composition and method
EP1597978A1 (fr) 2004-05-17 2005-11-23 Nutricia N.V. Synergie de GOS et polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US8992999B2 (en) 2004-06-25 2015-03-31 Alltech, Inc. Methods and compositions for controlling parasitic infections of animals
EP2248430A3 (fr) * 2005-02-15 2011-01-12 Barry R. Goldin Aliment contenant un probiotique et un bêta-glucane isolé et ses procédés d'utilisation
US20090263416A1 (en) * 2006-06-16 2009-10-22 Dawson Karl A Reduction of antibiotic resistance in bacteria
US20150147298A1 (en) * 2006-07-24 2015-05-28 CortControl, Inc. Sleep enhancement with cortisol reduction medical food
EP2219655A2 (fr) * 2007-11-13 2010-08-25 Biotec Pharmacon ASA Procédés de traitement ou de prévention de maladies inflammatoires du tractus intestinal
WO2010008272A1 (fr) * 2008-07-15 2010-01-21 N.V. Nutricia Traitement de troubles du transit intestinal
JP5320965B2 (ja) * 2008-10-09 2013-10-23 ダイソー株式会社 β−１，３−１，６−Ｄ−グルカンを用いた消化管粘膜保護剤または下痢抑制剤
MX348112B (es) 2009-12-22 2017-05-26 Probi Ab Composiciones no fermentadas que comprenden una fracción a base de cereal y un probiótico y usos de estos.
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
JP6506173B2 (ja) 2012-11-23 2019-04-24 セレス セラピューティクス インコーポレイテッド 相乗的細菌組成物並びにその生成及び使用の方法
BR112015018625A2 (pt) 2013-02-04 2017-09-19 Seres Therapeutics Inc composições e métodos
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
JP6372890B2 (ja) * 2013-03-08 2018-08-15 学校法人東京理科大学 乳酸菌増殖促進剤、制御性ｔ細胞増加剤、乳酸菌増殖促進方法、制御性ｔ細胞を増加させる方法、制御性ｔ細胞増加効果の評価方法、および乳酸菌増殖促進効果の評価方法
EP2971148A4 (fr) * 2013-03-14 2016-08-17 Seres Therapeutics Inc Procédés de détection de pathogènes et d'enrichissement à partir de matériaux et de compositions
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
EP3074027A1 (fr) 2013-11-25 2016-10-05 Seres Therapeutics, Inc. Compositions bactériennes synergiques et leurs procédés de production et d'utilisation
EP3082431A4 (fr) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
AU2018318132A1 (en) 2017-08-14 2020-02-27 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
CN110025639A (zh) * 2019-03-07 2019-07-19 浙江工业大学 酵母葡聚糖组合物在预防便秘中的应用
CN113841901A (zh) * 2021-09-15 2021-12-28 广西大学 一种高活性合生素制剂冻干粉的制备方法
WO2023241390A1 (fr) * 2022-06-16 2023-12-21 Nutricia Early Life Nutrition (Shanghai) Co., Ltd. Compositions et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
IT1274654B (it) * 1995-02-28 1997-07-18 Newpharma Srl Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production

Also Published As

Publication number Publication date
AUPO430496A0 (en) 1997-01-23
JP2001506129A (ja) 2001-05-15
WO1998026787A1 (fr) 1998-06-25

Similar Documents

Publication Publication Date Title
CA2275507A1 (fr) Prebiotiques et probiotiques
You et al. The promotion mechanism of prebiotics for probiotics: A review
US6348452B1 (en) Alteration of microbial populations in the gastrointestinal tract
Losada et al. Towards a healthier diet for the colon: the influence of fructooligosaccharides and lactobacilli on intestinal health
De Vrese et al. Probiotics and prebiotics: effects on diarrhea
Andersson et al. Health effects of probiotics and prebiotics A literature review on human studies
Floch et al. Probiotics and functional foods in gastrointestinal disorders
Narayan et al. Probiotics: current trends in the treatment of diarrhoea
US20100189702A1 (en) Compositions and methods for restoring bacterial flora
Floch et al. Probiotics and functional foods in gastrointestinal disorders
JP2009084215A (ja) 炎症性腸疾患予防・治療剤
Yap et al. Changes in infants faecal characteristics and microbiota by inulin supplementation
WO2021081362A1 (fr) Compositions symbiotiques pour microbiote intestinal
Chikkamath et al. The role of probiotics, prebiotics and synbiotic on human health and disease-A review
Rajput et al. Role of Plant-Derived Prebiotic in Modulation of Human Gut Microflora: A Review
Schellack et al. Overview of prebiotics, probiotics and synbiotics
Majeed et al. Probiotics for health and wellbeing
Nair et al. Emerging Era of “Biotics”: Prebiotics, Probiotics, and Synbiotics
Panggabean et al. A naturally-stabilized-and-balanced synbiotics as a catalyst to aid in healing anti-microbial-resistance-induced communicable and non-communicable diseases
AU722028B2 (en) Alteration of microbial populations in the gastrointestinal tract
Combrinck et al. Prebiotics, probiotics and synbiotics: An update
KR20030069231A (ko) 변비타입에 따른 장기능 개선용 조성물
Combrinck et al. Probiotics and Prebiotics
Combrinck et al. Probiotics and prebiotics
Bird et al. Dietary management of the intestinal microbiota using probiotics and prebiotics in human and animals

Legal Events

Date Code Title Description
FZDE Discontinued